Your search for evid returned 579 results

Your search for evid returned 579 results

Sort Results:

Relevant Recent

News

Early Use of RAAS Inhibitors May Benefit Children With Lupus Nephritis

Publish Date June 27, 2022

Real-world data on use of RAAS inhibitors can be used to support future pragmatic studies to optimize management of childhood-onset SLE, according to investigators.

News

COVID-19 Vaccine Does Not Increase CV Event Risk in Those With Existing Disease

Publish Date June 27, 2022

Findings show safety of BNT162b2 or CoronaVac vaccines in patients with cardiovascular disease

News

CDC Backs Moderna Vaccine for Those Aged 6 to 17

Publish Date June 27, 2022

ACIP endorsed the shots after hearing the latest evidence on the vaccine's effectiveness

News

FDA: JUUL E-Cigarette Products Banned in US

Publish Date June 24, 2022

Individual consumers are not restricted from having or using JUUL products; however, the Agency will ensure compliance by retailers.

News

USPSTF Recommends Against Vitamin E, Beta-Carotene Use for CVD and Cancer Prevention

Publish Date June 22, 2022

The USPSTF reviewed 17459 unique citations and 379 full-text articles to assess the benefits and harms of vitamin and mineral supplementation in healthy adults.

News

AAP Updates Recommendations for Safe Infant Sleep Practices

Publish Date June 22, 2022

Infants should be placed in supine position, on firm, flat, noninclined surface for every sleep

Drugs in the Pipeline

FDA Panel Votes on Pimavanserin for Alzheimer Disease Psychosis

Publish Date June 21, 2022

Although not bound by the committee’s recommendations, the Agency does take them into consideration when making decisions on approval.

Clinical Charts

Travel Vaccines

Publish Date June 15, 2022

Vaccine requirements and recommendations for international travel.

Drugs in the Pipeline

Novel 12-LOX Inhibitor Fast Tracked for Heparin-Induced Thrombocytopenia

Publish Date June 15, 2022

VLX-1005 is a first-in-class, selective small molecule inhibitor of 12-lipoxygenase, a key target within the arachidonic acid pathway.

Drugs in the Pipeline

Nasal Therapy Improves Symptoms, Inflammation in Patients With Chronic Sinusitis

Publish Date June 13, 2022

OPN-375 is currently marketed under the brand name Xhance for the treatment of nasal polyps in patients 18 years of age and older.